Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Randomization was conducted using an interactive web response system, assigning participants in a 6:1 ratio to one of several treatment arms: once-weekly subcutaneous Cagrilintide administered in doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo
(2024) 11:e00017
Whether youre coming off semaglutide or looking for safer options while pregnant, well help you stay on track without putting your baby at risk
"Water for injection"
US$ 28.02
US$ 22.39
US$ 26.85
US$ 23.60
US$ 29.50
